drugset / Trial / NCT01337804

A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)

NCT01337804

Phase 1 Completed 50 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

This study compares the bioequivalence of omeprazole administered as either Zegerid® powder for oral suspension 20 mg or as Prilosec 40 mg capsule to healthy participants.

Timeline

Start
2011-01
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg Oral
Subject Omeprazole Other / unclassified 40 mg Oral
Subject sodium bicarbonate Diagnostic / imaging agent Oral

Indications